Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
The Journal of Rheumatology
|
March 1, 1994
Effect of exercise on 99mTc-DTPA clearance from knees with effusions
M J James, L G Cleland, R D Gaffney, et al.
Immunology and Cell Biology
|
August 8, 2001
Recruitment of mononuclear leucocytes to osteoarthritic human synovial xenografts in the ears of SCID mice
L G Cleland, M Fusco, S M Proudman, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 31, 2015
Semiphysiologically Based Pharmacokinetic Model of Leflunomide Disposition in Rheumatoid Arthritis Patients
A M Hopkins, M D Wiese, S M Proudman, et al.
The Pharmacogenomics Journal
|
January 8, 2014
Pharmacogenomics of NAT2 and ABCG2 influence the toxicity and efficacy of sulphasalazine containing DMARD regimens in early rheumatoid arthritis
M D Wiese, N Alotaibi, C O'Doherty, et al.
Arthritis Care & Research
|
October 16, 2013
Decline in hand bone mineral density indicates increased risk of erosive change in early rheumatoid arthritis
R J Black, L Spargo, C Schultz, et al.
Internal Medicine Journal
|
May 15, 2013
Should patients with systemic sclerosis-related pulmonary arterial hypertension be anticoagulated?
M Nikpour, W Stevens, S M Proudman, et al.
Internal Medicine Journal
|
April 18, 2009
Treatment-induced stable, moderate reduction in blood cell counts correlate to disease control in early rheumatoid arthritis
S E Lester, S M Proudman, A T Y Lee, et al.
Journal of Clinical Pharmacy and Therapeutics
|
July 22, 2014
The rheumatoid arthritis susceptibility polymorphism PTPN22 C1858T is not associated with leflunomide response or toxicity
A M Hopkins, C E O'Doherty, D J R Foster, et al.
International Journal of Clinical Practice
|
March 19, 2016
Drug-induced toxicity and patient reported outcomes in rheumatoid arthritis patients following intensive treated-to-target strategy: does ceasing therapy due to toxicity worsen outcomes in long term?
N Wabe, M J Sorich, M D Wechalekar, et al.
Scandinavian Journal of Rheumatology
|
April 14, 2021
Anti-Ro52/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patients
Ays Lee, K A Patterson, D J Tan, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
The Journal of Rheumatology
|
March 1, 1994
Effect of exercise on 99mTc-DTPA clearance from knees with effusions
M J James, L G Cleland, R D Gaffney, et al.
Immunology and Cell Biology
|
August 8, 2001
Recruitment of mononuclear leucocytes to osteoarthritic human synovial xenografts in the ears of SCID mice
L G Cleland, M Fusco, S M Proudman, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 31, 2015
Semiphysiologically Based Pharmacokinetic Model of Leflunomide Disposition in Rheumatoid Arthritis Patients
A M Hopkins, M D Wiese, S M Proudman, et al.
The Pharmacogenomics Journal
|
January 8, 2014
Pharmacogenomics of NAT2 and ABCG2 influence the toxicity and efficacy of sulphasalazine containing DMARD regimens in early rheumatoid arthritis
M D Wiese, N Alotaibi, C O'Doherty, et al.
Arthritis Care & Research
|
October 16, 2013
Decline in hand bone mineral density indicates increased risk of erosive change in early rheumatoid arthritis
R J Black, L Spargo, C Schultz, et al.
Internal Medicine Journal
|
May 15, 2013
Should patients with systemic sclerosis-related pulmonary arterial hypertension be anticoagulated?
M Nikpour, W Stevens, S M Proudman, et al.
Internal Medicine Journal
|
April 18, 2009
Treatment-induced stable, moderate reduction in blood cell counts correlate to disease control in early rheumatoid arthritis
S E Lester, S M Proudman, A T Y Lee, et al.
Journal of Clinical Pharmacy and Therapeutics
|
July 22, 2014
The rheumatoid arthritis susceptibility polymorphism PTPN22 C1858T is not associated with leflunomide response or toxicity
A M Hopkins, C E O'Doherty, D J R Foster, et al.
International Journal of Clinical Practice
|
March 19, 2016
Drug-induced toxicity and patient reported outcomes in rheumatoid arthritis patients following intensive treated-to-target strategy: does ceasing therapy due to toxicity worsen outcomes in long term?
N Wabe, M J Sorich, M D Wechalekar, et al.
Scandinavian Journal of Rheumatology
|
April 14, 2021
Anti-Ro52/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patients
Ays Lee, K A Patterson, D J Tan, et al.
Page
of 3